Physician
Healthcare Associates in Medicine PC
Healthcare Associates in Medicine PC was paid $4.56M by Medicaid between Jan 2018 and Apr 2020, across 76 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoHEALTHCARE ASSOCIATES IN MEDICINE PC
STATEN ISLAND, NY 10304
STATEN ISLAND, NY 10304
33aNPI1740264332assigned 12/06/2005
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$4.56M
24GClaims61,169
24DCodes billed76
24AFirst – last monthJan 2018 – Apr 2020
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in New York
Rank by total paid#2 of 125
Median peer was paid$14K
This provider vs. median327×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,750 | $1.80M | |
| 2019 | 30,687 | $2.20M | |
| 2020 | 6,732 | $556K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 13,144 | 12,606 | $963K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 7,581 | 7,389 | $824K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 10% | 4,069 | 4,051 | $458K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 9.2% | 2,517 | 2,505 | $419K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 5.1% | 864 | 864 | $232K |
| 95816 | 5.0% | 690 | 687 | $227K | |
| 95886 | 3.7% | 1,108 | 1,003 | $167K | |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 3.6% | 1,924 | 783 | $166K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 2.9% | 523 | 523 | $132K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 2.2% | 365 | 355 | $100K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.9% | 2,726 | 1,006 | $88K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1.5% | 492 | 481 | $69K |
64 more codes
| 95912 | 1.5% | 288 | $68K | |
| 72141 | 1.4% | 273 | $66K | |
| 00630 | 1.4% | 298 | $64K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.2% | 2,560 | $56K |
| 95911 | 1.1% | 249 | $52K | |
| 20611 | <1% | 428 | $41K | |
| 95822 | <1% | 101 | $31K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 644 | $29K |
| 73560 | <1% | 785 | $26K | |
| 73610 | <1% | 852 | $25K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 197 | $22K |
| 72275 | <1% | 242 | $22K | |
| 73630 | <1% | 762 | $22K | |
| 95819 | <1% | 65 | $20K | |
| 97014 | <1% | 1,105 | $16K | |
| 73110 | <1% | 475 | $16K | |
| 97161 | <1% | 200 | $16K | |
| 96112 | <1% | 117 | $15K | |
| 20610 | <1% | 189 | $12K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 111 | $9K |
| 80305 | <1% | 1,100 | $9K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 502 | $8K |
| 73221 | <1% | 26 | $7K | |
| 93040 | <1% | 611 | $7K | |
| 73030 | <1% | 240 | $7K | |
| 95953 | <1% | 25 | $5K | |
| 73562 | <1% | 150 | $5K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 447 | $5K |
| 73140 | <1% | 158 | $5K | |
| 83789 | <1% | 448 | $4K | |
| 29540 | <1% | 198 | $4K | |
| 80363 | <1% | 842 | $2K | |
| 97165 | <1% | 32 | $2K | |
| 80323 | <1% | 829 | $2K | |
| 80349 | <1% | 797 | $2K | |
| 80346 | <1% | 726 | $2K | |
| 80324 | <1% | 730 | $2K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 112 | $2K |
| 83992 | <1% | 643 | $2K | |
| 80358 | <1% | 806 | $2K | |
| 96138 | <1% | 132 | $1K | |
| 96119 | <1% | 13 | $974.99 | |
| 80345 | <1% | 659 | $850.57 | |
| 97164 | <1% | 15 | $846.34 | |
| 80353 | <1% | 660 | $818.46 | |
| 73130 | <1% | 29 | $814.72 | |
| 72100 | <1% | 14 | $421.62 | |
| 80355 | <1% | 606 | $384.05 | |
| 96118 | <1% | 15 | $287.37 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 441 | $233.39 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 669 | $176.70 |
| 97010 | <1% | 463 | $175.84 | |
| G9584 | Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy | <1% | 39 | $157.50 |
| 96102 | <1% | 43 | $154.45 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 232 | $105.11 |
| 93225 | <1% | 13 | $103.24 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 648 | $100.09 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 20 | $86.83 |
| 82542 | <1% | 155 | $72.27 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 20 | $58.80 |
| 84311 | <1% | 157 | $25.89 | |
| 82570 | <1% | 157 | $19.17 | |
| 83986 | <1% | 157 | $13.26 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 446 | $1.40 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBERKLEY, PAUL (ADMINISTRATOR)